347 related articles for article (PubMed ID: 33961518)
1. Cancer Stem Cell Marker CD44 Plays Multiple Key Roles in Human Cancers: Immune Suppression/Evasion, Drug Resistance, Epithelial-Mesenchymal Transition, and Metastasis.
Dzobo K; Sinkala M
OMICS; 2021 May; 25(5):313-332. PubMed ID: 33961518
[TBL] [Abstract][Full Text] [Related]
2. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.
Geng S; Guo Y; Wang Q; Li L; Wang J
Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085
[TBL] [Abstract][Full Text] [Related]
3. Distinct biological characterization of the CD44 and CD90 phenotypes of cancer stem cells in gastric cancer cell lines.
Shu X; Liu H; Pan Y; Sun L; Yu L; Sun L; Yang Z; Ran Y
Mol Cell Biochem; 2019 Sep; 459(1-2):35-47. PubMed ID: 31073886
[TBL] [Abstract][Full Text] [Related]
4. Chitinase 3-like 1-CD44 interaction promotes metastasis and epithelial-to-mesenchymal transition through β-catenin/Erk/Akt signaling in gastric cancer.
Geng B; Pan J; Zhao T; Ji J; Zhang C; Che Y; Yang J; Shi H; Li J; Zhou H; Mu X; Xu C; Wang C; Xu Y; Liu Z; Wen H; You Q
J Exp Clin Cancer Res; 2018 Aug; 37(1):208. PubMed ID: 30165890
[TBL] [Abstract][Full Text] [Related]
5. CD44 Sorted Cells Have an Augmented Potential for Proliferation, Epithelial-Mesenchymal Transition, Stemness, and a Predominantly Inflammatory Cytokine and Angiogenic Secretome.
Patil S
Curr Issues Mol Biol; 2021 Jun; 43(1):423-433. PubMed ID: 34205649
[TBL] [Abstract][Full Text] [Related]
6. siRNA-induced CD44 knockdown suppresses the proliferation and invasion of colorectal cancer stem cells through inhibiting epithelial-mesenchymal transition.
Zou W; Zhang Y; Bai G; Zhuang J; Wei L; Wang Z; Sun M; Wang J
J Cell Mol Med; 2022 Apr; 26(7):1969-1978. PubMed ID: 35229451
[TBL] [Abstract][Full Text] [Related]
7. Epithelial mesenchymal transition and pancreatic tumor initiating CD44+/EpCAM+ cells are inhibited by γ-secretase inhibitor IX.
Palagani V; El Khatib M; Kossatz U; Bozko P; Müller MR; Manns MP; Krech T; Malek NP; Plentz RR
PLoS One; 2012; 7(10):e46514. PubMed ID: 23094026
[TBL] [Abstract][Full Text] [Related]
8. Impact of in vitro driven expression signatures of CD133 stem cell marker and tumor stroma on clinical outcomes in gastric cancers.
Kim TM; Ko YH; Ha SJ; Lee HH
BMC Cancer; 2019 Feb; 19(1):119. PubMed ID: 30717708
[TBL] [Abstract][Full Text] [Related]
9. Identification of a subpopulation of long-term tumor-initiating cells in colon cancer.
Peng L; Xiong Y; Wang R; Xiang L; Zhou H; Gu H
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32729895
[TBL] [Abstract][Full Text] [Related]
10. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
[TBL] [Abstract][Full Text] [Related]
11. Lgr5+CD44+EpCAM+ Strictly Defines Cancer Stem Cells in Human Colorectal Cancer.
Leng Z; Xia Q; Chen J; Li Y; Xu J; Zhao E; Zheng H; Ai W; Dong J
Cell Physiol Biochem; 2018; 46(2):860-872. PubMed ID: 29627827
[TBL] [Abstract][Full Text] [Related]
12. Predictive Value of CD44 in Muscle-Invasive Bladder Cancer and Its Relationship with IL-6 Signaling.
Wu CT; Lin WY; Chen WC; Chen MF
Ann Surg Oncol; 2018 Nov; 25(12):3518-3526. PubMed ID: 30128900
[TBL] [Abstract][Full Text] [Related]
13. miR‑196a‑5p modulates gastric cancer stem cell characteristics by targeting Smad4.
Pan Y; Shu X; Sun L; Yu L; Sun L; Yang Z; Ran Y
Int J Oncol; 2017 Jun; 50(6):1965-1976. PubMed ID: 28440445
[TBL] [Abstract][Full Text] [Related]
14. Enrichment of cancer stem-like cells by the induction of epithelial-mesenchymal transition using lentiviral vector carrying E-cadherin shRNA in HT29 cell line.
Saltanatpour Z; Johari B; Alizadeh A; Lotfinia M; Majidzadeh-A K; Nikbin B; Kadivar M
J Cell Physiol; 2019 Dec; 234(12):22935-22946. PubMed ID: 31111504
[TBL] [Abstract][Full Text] [Related]
15. Expression of epithelial-mesenchymal transition and cancer stem cell markers in colorectal adenocarcinoma: Clinicopathological significance.
Choi JE; Bae JS; Kang MJ; Chung MJ; Jang KY; Park HS; Moon WS
Oncol Rep; 2017 Sep; 38(3):1695-1705. PubMed ID: 28677737
[TBL] [Abstract][Full Text] [Related]
16. CD44: A Multifunctional Mediator of Cancer Progression.
Hassn Mesrati M; Syafruddin SE; Mohtar MA; Syahir A
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944493
[TBL] [Abstract][Full Text] [Related]
17. Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells.
Alberti L; Losi L; Leyvraz S; Benhattar J
PLoS One; 2015; 10(7):e0132977. PubMed ID: 26185996
[TBL] [Abstract][Full Text] [Related]
18. Functional heterogeneity within the CD44 high human breast cancer stem cell-like compartment reveals a gene signature predictive of distant metastasis.
Leth-Larsen R; Terp MG; Christensen AG; Elias D; Kühlwein T; Jensen ON; Petersen OW; Ditzel HJ
Mol Med; 2012 Sep; 18(1):1109-21. PubMed ID: 22692575
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of CD44 in human colon cancer and gastric cancer: Evidence from bioinformatic analyses.
Xia P; Xu XY
Oncotarget; 2016 Jul; 7(29):45538-45546. PubMed ID: 27323782
[TBL] [Abstract][Full Text] [Related]
20. Re-expression of miR-21 contributes to migration and invasion by inducing epithelial-mesenchymal transition consistent with cancer stem cell characteristics in MCF-7 cells.
Han M; Liu M; Wang Y; Mo Z; Bi X; Liu Z; Fan Y; Chen X; Wu C
Mol Cell Biochem; 2012 Apr; 363(1-2):427-36. PubMed ID: 22187223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]